Tests an activity coaching program for people with long COVID symptoms
Tests remote activity coaching against standard care in adults with lingering COVID-19 symptoms.
Plain-language title generated from the registry record
Registry title: Improving Health Status in COVID-19 Long-Hauler
Key facts
- Where
- Granada, SpainSee the site
Where in Spain
- Faculty of Health Sciences. University of GranadaGranada, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidad de Granada
- Trial code
- NCT06679218
- Record updated
- 7 November 2024
- Original description
This randomized clinical trial investigates the effects of a distance physical activity coaching program on the health of COVID-19 long-hauler. The study evaluates the impact of individualized coaching interventions to improve participants' physical activity and quality of life.Read full original descriptionShow less
Improving Health Status in COVID-19 Long-Hauler Through an Activity Coaching Programme: a Randomized Control Trial
This randomized clinical trial investigates the effects of a distance physical activity coaching program on the health of COVID-19 long-hauler. The study evaluates the impact of individualized coaching interventions to improve participants' physical activity and quality of life.
Inclusion: Patients of both sexes; Agreed to participate; Post COVID-19 condition patients meeting the WHO definition for this disease; Sedentary patients according to the cut-off point of the International Physical Activity Questionnaire (IPAQ).
Exclusion: Pulmonary, cardiac, neurological, vascular, or orthopaedic pathologies that could limit the execution of the evaluation and intervention; Cognitive impairment that prevented them from understanding and answering the questionnaires; Patients with a history of severe or critical COVID-19 disease severity; Patients suffering from a reinfection with SARS-CoV-2; Patients participating in other studies.